CDCA5 overexpression is an indicator of poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder

I. Wei Chang, Victor Chia Hsiang Lin, Hong Lin He, Chao Tien Hsu, Ching Chia Li, Wen Jeng Wu, Chun Nung Huang, Ting Feng Wu, Chien Feng Li

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Aims: Urothelial carcinoma (UC) is the most common tumor involving upper urinary tract (UTUC) and urinary bladder (UBUC) whose molecular survival determinants remains obscured. By computerizing a public transcriptomic database of UBUCs (GSE32894), we identified cell division cycle associated 5 (CDCA5) as the most significantly upregulated gene among those associated with G1-S transition of the mitotic cell cycle (GO:0000082). We therefore analyzed the clinicoptaological significance of CDCA5 expression in our well-characterized UC cohort. Methods and results: Quantigene assay was used to detect CDCA5 transcript levels in 36 UTUCs and 30 UBUCs. We used immunohistochemistry evaluated by H-scores to determine CDCA5 protein expression in 295 UBUCs and 340 UTUCs, respectively. CDCA5 expression was further correlated with clinicopathological features and diseasespecific survival (DSS) and metastasis-free survival (MeFS). For both groups of UCs, increments of CDCA5 transcript levels were associated with higher pT status, CDCA5 protein overexpression was also significantly associated with advanced pT status, nodal metastasis, high histological grade, vascular invasion, and frequent mitoses. CDCA5 overexpression was predictive for worse DSS and MeFS in univariate and multivariate analysis. Conclusions: CDCA5 overexpression is associated with advanced clinical features of UC, suggesting its potential value as a prognostic biomarker and a novel therapeutic target.

Original languageEnglish
Pages (from-to)710-722
Number of pages13
JournalAmerican Journal of Translational Research
Volume7
Issue number4
Publication statusPublished - Jan 1 2015
Externally publishedYes

Fingerprint

Urinary Tract
Cell Cycle
Urinary Bladder
Cells
Carcinoma
Biomarkers
Tumors
Assays
Proteins
Genes
Survival
Neoplasm Metastasis
Mitosis
Blood Vessels
Multivariate Analysis
Immunohistochemistry
Databases

Keywords

  • CDCA5
  • Cell division cycle associated 5
  • Upper tract
  • Urinary bladder
  • Urothelial carcinoma

ASJC Scopus subject areas

  • Molecular Medicine
  • Clinical Biochemistry
  • Cancer Research

Cite this

CDCA5 overexpression is an indicator of poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder. / Chang, I. Wei; Lin, Victor Chia Hsiang; He, Hong Lin; Hsu, Chao Tien; Li, Ching Chia; Wu, Wen Jeng; Huang, Chun Nung; Wu, Ting Feng; Li, Chien Feng.

In: American Journal of Translational Research, Vol. 7, No. 4, 01.01.2015, p. 710-722.

Research output: Contribution to journalArticle

Chang, I. Wei ; Lin, Victor Chia Hsiang ; He, Hong Lin ; Hsu, Chao Tien ; Li, Ching Chia ; Wu, Wen Jeng ; Huang, Chun Nung ; Wu, Ting Feng ; Li, Chien Feng. / CDCA5 overexpression is an indicator of poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder. In: American Journal of Translational Research. 2015 ; Vol. 7, No. 4. pp. 710-722.
@article{277f887d0bd8499686f308f2c53d2454,
title = "CDCA5 overexpression is an indicator of poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder",
abstract = "Aims: Urothelial carcinoma (UC) is the most common tumor involving upper urinary tract (UTUC) and urinary bladder (UBUC) whose molecular survival determinants remains obscured. By computerizing a public transcriptomic database of UBUCs (GSE32894), we identified cell division cycle associated 5 (CDCA5) as the most significantly upregulated gene among those associated with G1-S transition of the mitotic cell cycle (GO:0000082). We therefore analyzed the clinicoptaological significance of CDCA5 expression in our well-characterized UC cohort. Methods and results: Quantigene assay was used to detect CDCA5 transcript levels in 36 UTUCs and 30 UBUCs. We used immunohistochemistry evaluated by H-scores to determine CDCA5 protein expression in 295 UBUCs and 340 UTUCs, respectively. CDCA5 expression was further correlated with clinicopathological features and diseasespecific survival (DSS) and metastasis-free survival (MeFS). For both groups of UCs, increments of CDCA5 transcript levels were associated with higher pT status, CDCA5 protein overexpression was also significantly associated with advanced pT status, nodal metastasis, high histological grade, vascular invasion, and frequent mitoses. CDCA5 overexpression was predictive for worse DSS and MeFS in univariate and multivariate analysis. Conclusions: CDCA5 overexpression is associated with advanced clinical features of UC, suggesting its potential value as a prognostic biomarker and a novel therapeutic target.",
keywords = "CDCA5, Cell division cycle associated 5, Upper tract, Urinary bladder, Urothelial carcinoma",
author = "Chang, {I. Wei} and Lin, {Victor Chia Hsiang} and He, {Hong Lin} and Hsu, {Chao Tien} and Li, {Ching Chia} and Wu, {Wen Jeng} and Huang, {Chun Nung} and Wu, {Ting Feng} and Li, {Chien Feng}",
year = "2015",
month = "1",
day = "1",
language = "English",
volume = "7",
pages = "710--722",
journal = "American Journal of Translational Research",
issn = "1943-8141",
publisher = "e-Century Publishing Corporation",
number = "4",

}

TY - JOUR

T1 - CDCA5 overexpression is an indicator of poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder

AU - Chang, I. Wei

AU - Lin, Victor Chia Hsiang

AU - He, Hong Lin

AU - Hsu, Chao Tien

AU - Li, Ching Chia

AU - Wu, Wen Jeng

AU - Huang, Chun Nung

AU - Wu, Ting Feng

AU - Li, Chien Feng

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Aims: Urothelial carcinoma (UC) is the most common tumor involving upper urinary tract (UTUC) and urinary bladder (UBUC) whose molecular survival determinants remains obscured. By computerizing a public transcriptomic database of UBUCs (GSE32894), we identified cell division cycle associated 5 (CDCA5) as the most significantly upregulated gene among those associated with G1-S transition of the mitotic cell cycle (GO:0000082). We therefore analyzed the clinicoptaological significance of CDCA5 expression in our well-characterized UC cohort. Methods and results: Quantigene assay was used to detect CDCA5 transcript levels in 36 UTUCs and 30 UBUCs. We used immunohistochemistry evaluated by H-scores to determine CDCA5 protein expression in 295 UBUCs and 340 UTUCs, respectively. CDCA5 expression was further correlated with clinicopathological features and diseasespecific survival (DSS) and metastasis-free survival (MeFS). For both groups of UCs, increments of CDCA5 transcript levels were associated with higher pT status, CDCA5 protein overexpression was also significantly associated with advanced pT status, nodal metastasis, high histological grade, vascular invasion, and frequent mitoses. CDCA5 overexpression was predictive for worse DSS and MeFS in univariate and multivariate analysis. Conclusions: CDCA5 overexpression is associated with advanced clinical features of UC, suggesting its potential value as a prognostic biomarker and a novel therapeutic target.

AB - Aims: Urothelial carcinoma (UC) is the most common tumor involving upper urinary tract (UTUC) and urinary bladder (UBUC) whose molecular survival determinants remains obscured. By computerizing a public transcriptomic database of UBUCs (GSE32894), we identified cell division cycle associated 5 (CDCA5) as the most significantly upregulated gene among those associated with G1-S transition of the mitotic cell cycle (GO:0000082). We therefore analyzed the clinicoptaological significance of CDCA5 expression in our well-characterized UC cohort. Methods and results: Quantigene assay was used to detect CDCA5 transcript levels in 36 UTUCs and 30 UBUCs. We used immunohistochemistry evaluated by H-scores to determine CDCA5 protein expression in 295 UBUCs and 340 UTUCs, respectively. CDCA5 expression was further correlated with clinicopathological features and diseasespecific survival (DSS) and metastasis-free survival (MeFS). For both groups of UCs, increments of CDCA5 transcript levels were associated with higher pT status, CDCA5 protein overexpression was also significantly associated with advanced pT status, nodal metastasis, high histological grade, vascular invasion, and frequent mitoses. CDCA5 overexpression was predictive for worse DSS and MeFS in univariate and multivariate analysis. Conclusions: CDCA5 overexpression is associated with advanced clinical features of UC, suggesting its potential value as a prognostic biomarker and a novel therapeutic target.

KW - CDCA5

KW - Cell division cycle associated 5

KW - Upper tract

KW - Urinary bladder

KW - Urothelial carcinoma

UR - http://www.scopus.com/inward/record.url?scp=84930391458&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930391458&partnerID=8YFLogxK

M3 - Article

VL - 7

SP - 710

EP - 722

JO - American Journal of Translational Research

JF - American Journal of Translational Research

SN - 1943-8141

IS - 4

ER -